Foto del docente

Nazzareno Galiè

Full Professor

Department of Experimental, Diagnostic and Specialty Medicine - DIMES

Academic discipline: MED/11 Cardiovascular Diseases

Head of Scuola di Specializzazione Malattie dell'Apparato Cardiovascolare (Di 68/2015)


vai alle Pubblicazioni

Publications prior to 2004

  • Galiè N, Manes A, Branzi A. Prostanoids for pulmonary arterial hypertension. Am J Respir Med. 2003;2(2):123-37. Review. PubMed PMID: 14720012.
  • Torbicki A, Galié N, Covezzoli A, Rossi E, De Rosa M, Goldhaber SZ; ICOPER Study Group. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol. 2003 Jun 18;41(12):2245-51. PubMed PMID: 12821255.
  • Galiè N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, Espinola-Zavaleta N, Rocchi G, Manes A, Frantz R, Kurzyna M, Nagueh SF, Barst R, Channick R, Dujardin K, Kronenberg A, Leconte I, Rainisio M, Rubin L. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Apr 16;41(8):1380-6. PubMed PMID: 12706935.
  • Galiè N, Manes A, Branzi A. Emerging medical therapies for pulmonary arterial hypertension. Prog Cardiovasc Dis. 2002 Nov-Dec;45(3):213-24. Review. PubMed PMID: 12525997.
  • Galiè N, Manes A, Branzi A. The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J. 2002 Oct;20(4):1037-49. Review. PubMed PMID: 12412701.
  • Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W; Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002 Aug 1;347(5):322-9. PubMed PMID: 12151469.
  • Langleben D, Christman BW, Barst RJ, Dias VC, Galiè N, Higenbottam TW, Kneussl M, Korducki L, Naeije R, Riedel A, Simonneau G, Hirsch AM, Rich S, Robbins IM, Oudiz R, McGoon MD, Badesch DB, Levy RD, Mehta S, Seeger W, Solèr M.Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. Am Heart J. 2002 May;143(5):E4. PubMed PMID: 12040360.
  • Hoeper MM, Galiè N, Simonneau G, Rubin LJ. New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002 May 1;165(9):1209-16. Review. PubMed PMID: 11991870.
  • Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2002 May 1;39(9):1496-502. PubMed PMID: 11985913.
  • Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002 Mar 21;346(12):896-903. Erratum in: N Engl J Med 2002 Apr 18;346(16):1258. PubMed PMID: 11907289.
  • Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, OudizR, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients withpulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4. PubMed PMID: 11897647.
  • Hoeper MM, Galié N, Murali S, Olschewski H, Rubenfire M, Robbins IM, FarberHW, McLaughlin V, Shapiro S, Pepke-Zaba J, Winkler J, Ewert R, Opitz C, Westerkamp V, Vachiéry JL, Torbicki A, Behr J, Barst RJ. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002 Feb 1;165(3):341-4. PubMed PMID: 11818318.
  • Galié N, Manes A, Branzi A. Medical therapy of pulmonary hypertension. The prostacyclins. Clin Chest Med. 2001 Sep;22(3):529-37, x. Review. PubMed PMID: 11590846.
  • Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001 Aug 2;345(5):325-34. PubMed PMID: 11484689.
  • Galiè N. Do we need controlled clinical trials in pulmonary arterial hypertension? Eur Respir J. 2001 Jan;17(1):1-3. PubMed PMID: 11307737.
  • Galiè N, Torbicki A. Pulmonary arterial hypertension: new ideas and perspectives. Heart. 2001 Apr;85(4):475-80. Review. PubMed PMID: 11250981; PubMed Central PMCID: PMC1729670.
  • Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet. 2001 Jan;68(1):92-102. Epub 2000 Dec 12. PubMed PMID: 11115378; PubMed Central PMCID: PMC1234937.
  • Galiè N. Medical therapy of pulmonary arterial hypertension. Ital Heart J. 2000 Sep;1 Suppl 3:S110-1. PubMed PMID: 11003038.
  • Galiè N, Manes A, Uguccioni L, Serafini F, De Rosa M, Branzi A, Magnani B. Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest. 1998 Sep;114(3 Suppl):184S-194S. Review. PubMed PMID: 9741567.
  • Ferlini A, Galié N, Merlini L, Sewry C, Branzi A, Muntoni F. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet. 1998 Aug;63(2):436-46. PubMed PMID: 9683584; PubMed Central PMCID: PMC1377294.
  • Magnani B, Galiè N. Prostacyclin in primary pulmonary hypertension. Eur Heart J. 1996 Jan;17(1):18-24. Review. PubMed PMID: 8682125.
  • Galiè N, Ussia GP, Catanzariti P, Grigioni F, Parlangeli R, Serafini F, Uguccioni L, Branzi A, Magnani B. [Myocardial protection from ischemic damage: effects of preconditioning and pharmacologic activation of KATP channels]. Cardiologia. 1995 Dec;40(12 Suppl 1):77-82. Review. Italian. PubMed PMID: 8998785.
  • Galiè N, Guarnieri C, Ussia GP, Zimarino M, Traini AM, Parlangeli R, Vaona I, Branzi A, Magnani B. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol. 1995 Sep;26(3):477-84. PubMed PMID: 8583791.
  • Galiè N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol. 1995 Jan 19;75(3):55A-62A. Review. PubMed PMID: 7840056.
  • Fattori R, Rapezzi C, Castriota F, Magnani G, Bertaccini P, Galiè N, Magnani B, Gavelli G. [Clinical significance of magnetic resonance and echocardiographiccorrelations in the evaluation of hypertrophic cardiomyopathy]. Radiol Med. 1994Jul-Aug;88(1-2):36-43. Italian. PubMed PMID: 8066253.
  • Rapezzi C, Fattori R, Castriota F, Passarelli P, Magnani G, Galiè N, Ferlito M, Bertaccini P, Branzi A, Gavelli G, et al. [The role of magnetic resonance in studying hypertrophic cardiomyopathy: the echocardiographic correlations and clinical implications]. Cardiologia. 1994 Jan;39(1):7-15. Italian. PubMed PMID: 8020058.
  • Galiè N, Magelli C, Rapezzi C, Branzi A, Magnani B. [Vasodilator agents: the lesson from large clinical trials]. Cardiologia. 1993 Dec;38(12 Suppl 1):221-6. Review. Italian. PubMed PMID: 8020020.
  • Rapezzi C, Assirelli C, Ortolani P, Ferlito M, Turinetto B, Fattori R, Galiè N, Castelli G, Branzi A, Pierangeli A, et al. [Role of transesophageal echography in the diagnosis of aortic dissection and in therapy programming]. Cardiologia. 1993 Nov;38(11):713-21. Italian. PubMed PMID: 8004643.
  • Galie N, Branzi A, Magnani G, Melandri G, Caldarera I, Rapezzi C, Grattoni C, Magnani B. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile. Cardiovasc Drugs Ther. 1993 Jun;7(3):337-47. PubMed PMID: 8364004.
  • Magnani B, Rapezzi C, Galié N, Ortolani P. Use of multiple-action agents on the heart: pathophysiological and therapeutic considerations. J Cardiovasc Pharmacol. 1992;19 Suppl 1:S44-9. Review. PubMed PMID: 1378149.
  • Branzi A, Melandri G, Galié N. [The management of postthrombolysis patients]. Cardiologia. 1991 Dec;36(12 Suppl 1):413-9. Review. Italian. PubMed PMID: 1688159.
  • Passarelli P, Galiè N, Limonetti P, Branzi A, Magnani B. [Comparative effects of doxazosin and enalapril in patients with arterial hypertension and exercise-induced acute myocardial ischemia]. Cardiologia. 1991 Oct;36(10):777-83. Italian. PubMed PMID: 1686851.
  • Melandri G, Branzi A, Semprini F, Cervi V, Galiè N, Magnani B. Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin. Br Heart J. 1990 Aug;64(2):118-20. PubMed PMID: 2203397; PubMed Central PMCID: PMC1024350.
  • Galié N, Varani E, Maiello L, Boriani G, Boschi S, Binetti G, Magnani B. Usefulness of nicorandil in congestive heart failure. Am J Cardiol. 1990 Feb 1;65(5):343-8. PubMed PMID: 2137279.
  • Galiè N, Metalli M, Zannoli R, Binetti G, Branzi A, Magnani B. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs. Cardiovasc Drugs Ther. 1989 Mar;3(1):91-7. PubMed PMID: 2577281.
  • Branzi A, Rapezzi C, Galiè N. [Beta-blocker therapy in heart failure: rational basis, indications, dosages and cautions]. G Ital Cardiol. 1988 Dec;18(12):1072-9. Review. Italian. PubMed PMID: 2908108.
  • Branzi A, Galiè N, Metalli M, Rapezzi C. [Surgical indications in acquired tricuspid valvulopathies]. Cardiologia. 1988 Apr;33(4):347-52. Review. Italian. PubMed PMID: 3044587.
  • Melandri G, Branzi A, Berardi C, Bruscoli F, Tartagni F, Binetti G, Galiè N, Magnani B, Gensini GF, Abbate R, et al. [Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo]. Cardiologia. 1987 Jul;32(7):619-26. Italian. PubMed PMID: 3319156.
  • Branzi A, Galiè N, Specchia S, Binetti G, Ferretti RM, Berardi C, Magnani G, Zannoli R, Magnani B. [Functional evaluation of heart insufficiency]. Cardiologia. 1986 Nov;31(11):955-61. Italian. PubMed PMID: 3829071.
  • Seth L, Galiè N, Casebolt P, Gimenez H, Malloy M, Franciosa JA. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity. Clin Pharmacol Ther. 1986 Nov;40(5):567-74. PubMed PMID: 3769387.
  • Baker BJ, Leddy C, Galié N, Casebolt P, Franciosa JA. Predictive value of M-mode echocardiography in patients with congestive heart failure. Am Heart J. 1986 Apr;111(4):697-702. PubMed PMID: 3953392.
  • Maresta A, Marzocchi A, Capucci A, Galiè N, Marrozzini C, Magnani B. Nifedipine compared with verapamil in unstable angina pectoris. Int J Clin Pharmacol Res. 1986;6(4):291-301. PubMed PMID: 3759282.
  • Galiè N, Sanguinetti M, Marrozzini C, Magnani B. [Vasodilator therapy in chronic thromboembolic cor pulmonare. Description of a case with unfavorable hemodynamic effects]. G Ital Cardiol. 1985 Oct;15(10):992-4. Italian. PubMed PMID: 4092919.
  • Galiè N, Magelli C, Ribani MA, Bassein L, Sanguinetti M, Magnani B. [Hemodynamic and clinical effects of captopril in congestive heart failure]. G Ital Cardiol. 1985 Jan;15(1):70-9. Italian. PubMed PMID: 3891488.
  • Marzocchi A, Ferretti RM, Galiè N, Magelli C, Marrozzini C, Magnani B. [Review of the criteria for a positive electrocardiographic exercise test in 109patients studied with coronary arteriography]. Minerva Cardioangiol. 1982 May;30(5):223-30. Review. Italian. PubMed PMID: 6752750.
  • Sanguinetti M, Galiè N, Magelli C, Orselli L, Magnani B. [Precapillary pulmonary hypertension: effect of Captopril]. G Ital Cardiol. 1982;12(6):436-41.Italian. PubMed PMID: 6761221.